Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability
PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...
hospitalnews4d
Sinai Health team sheds light on COVID-19 variant dynamics in Toronto
Get up-to-date information on the dynamics of COVID-19 variants in Toronto. Discover how this research can aid in fighting ...
How the virus behind COVID-19 can harm your blood vessels and your heart
It started as a respiratory illness—or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...
AZoLifeSciences on MSN4d
New Microfluidic Device can Detect SARS-Cov-2 with Revolutionary Sensitivity
VirusHB-Chip offers groundbreaking sensitivity in detecting SARS-CoV-2 in plasma, saliva, and stool, transforming COVID-19 diagnostics and treatment strategies.